<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Spontaneous coronary artery dissection</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Spontaneous coronary artery dissection</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Spontaneous coronary artery dissection</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jacqueline Saw, MD, FRCPC, FACC</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Juan Carlos Kaski, DSc, MD, DM (Hons), FRCP, FESC, FACC, FAHA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Patricia A Pellikka, MD, FACC, FAHA, FASE</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 30, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H436342788"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Spontaneous coronary artery dissection (SCAD) is a nontraumatic, noniatrogenic separation of the coronary arterial wall and is an infrequent cause of acute myocardial infarction. It is more common in younger patients and in women. Modern usage of the term SCAD denotes nonatherosclerotic causes, which is the primary focus of this topic. Other aspects of coronary heart disease in women and among the general population are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1467.html" rel="external">"Clinical features and diagnosis of coronary heart disease in women"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/50.html" rel="external">"Coronary artery disease and myocardial infarction in young people"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/184.html" rel="external">"Initial evaluation and management of suspected acute coronary syndrome (myocardial infarction, unstable angina) in the emergency department"</a>.)</p><p></p><p class="headingAnchor" id="H1589962407"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H45885115"><span class="h2">Incidence and prevalence</span><span class="headingEndMark"> — </span>In<strong> </strong>a Danish study, annual SCAD incidence was 0.7 among patients referred for angiogram and 0.2 among patients with acute coronary syndrome (ACS) [<a href="#rid1">1</a>]. In the general population, SCAD is the cause of ACS in 0.1 to 4 percent of cases [<a href="#rid1">1-4</a>]. </p><p>The following prevalence has been described from the National Inpatient Sample (NIS): </p><p class="bulletIndent1"><span class="glyph">●</span>In a 2018 report of NIS of over 13 million patients who presented with an ACS between 2005 and 2015, the incidence of SCAD was reported at 0.49 percent [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a 2009 to 2014 study of 750,000 patients with myocardial infarction who underwent coronary angiography, SCAD was reported in 0.98 percent [<a href="#rid6">6</a>]. </p><p></p><p class="bulletIndent1">However, these estimates likely under-reported the true incidence of SCAD, as this disease was underdiagnosed and misdiagnosed, especially during that time period.</p><p></p><p class="bulletIndent1">Among women ≤50 years old with ACS, SCAD may account for nearly one-quarter of cases [<a href="#rid7">7</a>]. </p><p></p><p class="headingAnchor" id="H4139816015"><span class="h2">Sex</span><span class="headingEndMark"> — </span>SCAD is more common in females than males.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>SCAD in females </strong>– Although classically thought to affect young women, SCAD is now increasingly recognized to also occur in older and postmenopausal women. In 327 patients, 57 percent of women affected were postmenopausal [<a href="#rid8">8</a>]. In the largest multicenter prospective SCAD registry to date (the Canadian SCAD Cohort Study), the mean age of the 750 SCAD patients was 51.8 years, with 9.2 percent older than age 65, and 88.5 percent were women [<a href="#rid9">9</a>]. In two other studies of 87 and 168 patients, the mean age was 43 and 52 years, and 82 and 92 percent were women, respectively [<a href="#rid7">7,10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>SCAD in males </strong>– Men account for &lt;10 to 15 percent of SCAD cases. However, mechanistically, males are more likely to have coronary dissection that is related to atherosclerosis rather than nonatherosclerotic SCAD [<a href="#rid11">11</a>]. Men present at slightly younger ages (mean age 48.6 versus 52.3 years in women) [<a href="#rid12">12</a>].<strong> </strong></p><p></p><p class="headingAnchor" id="H3533674279"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>The underlying mechanism of nonatherosclerotic SCAD is not fully understood. Proposed mechanisms likely include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intimal tear and bleeding of vasa vasorum</strong> – These processes result in intramedial hemorrhage [<a href="#rid13">13</a>]. This can result in the creation of a false lumen filled with intramural hematoma [<a href="#rid14">14</a>]. </p><p></p><p class="bulletIndent1">Pressure-driven expansion of the false lumen by an enlarging hematoma may lead to luminal encroachment and subsequent myocardial ischemia and infarction. Intramural hematoma involving the outer two-thirds of the media is common. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Inflammation </strong>– Histological studies have shown an inflammatory reaction (eg, eosinophilic infiltrates) in the adventitia. This is suggestive of periarteritis that may breakdown the medial-adventitial layer predisposing the artery to dissection. However, this inflammatory response may be reactive rather than causative [<a href="#rid15">15</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tortuosity </strong>– One retrospective study has proposed that coronary artery tortuosity may be a marker for or a potential mechanism for SCAD [<a href="#rid16">16</a>]. In this study, the coronary angiograms of 246 patients with SCAD were compared with 313 controls. Tortuosity, as defined by the presence of ≥3 consecutive curvatures of 90 to 180 degrees measured at end-diastole in a major epicardial coronary artery ≥2 mm in diameter, was found in 78 and 17 percent, respectively. However, the presence of coronary tortuosity was also associated with extracoronary vasculopathy (eg, fibromuscular dysplasia [FMD]) [<a href="#rid17">17,18</a>]; as such, it is more likely that the tortuosity (similar to dissection) is a manifestation of the underlying predisposing vasculopathy. </p><p></p><p>Whereas <strong>nonatherosclerotic</strong> SCAD can cause extensive dissection lengths (especially in the presence of arterial fragility from predisposing arteriopathies) [<a href="#rid19">19,20</a>], SCAD associated with <strong>atherosclerosis </strong>is typically limited in extent by medial atrophy and scarring [<a href="#rid21">21</a>]. </p><p class="headingAnchor" id="H3405782249"><span class="h1">ETIOLOGIES AND DISEASE ASSOCIATIONS</span><span class="headingEndMark"> — </span>In over 50 percent of SCAD cases, there are identifiable cardiocirculatory stressors that may increase the risk of acute SCAD events; this is especially true if there is preexisting arteriopathy such as fibromuscular dysplasia (FMD) [<a href="#rid8">8,10</a>]. Recreational drug use and high-dose hormonal therapy have also been described as etiologies in these studies. </p><p class="headingAnchor" id="H3839864522"><span class="h2">Idiopathic</span><span class="headingEndMark"> — </span>In most cases, a predisposing arterial disease association or cause is identified [<a href="#rid22">22</a>]. However, up to 20 percent of cases are labeled as idiopathic [<a href="#rid10">10</a>]. </p><p class="headingAnchor" id="H152264557"><span class="h2">Pregnancy and postpartum</span><span class="headingEndMark"> — </span>Postpartum status was reported in 2 to 18 percent of cases [<a href="#rid7">7,9,10</a>]. In these patients, dissection may be a consequence of increased physiological hemodynamic stresses or from hormonal effects weakening the coronary arterial wall [<a href="#rid15">15,23</a>]. The exposure to recurrent and chronic hormonal pregnancy changes can further increase SCAD risks in women with multiple previous births (multiparity) [<a href="#rid23">23</a>].</p><p>Patients with pregnancy-associated SCAD have more severe presentations and may be at higher risk for recurrence. (See <a class="local">'Pregnancy, preconception counseling, and contraception'</a> below.)</p><p class="headingAnchor" id="H3889508386"><span class="h2">Other hormonal causes</span><span class="headingEndMark"> — </span>In addition to pregnancy, SCAD has been associated with other hormonal changes (some of these may also be considered a trigger of SCAD). (See <a class="local">'Triggers'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span>In vitro fertilization [<a href="#rid24">24</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Hormonal therapy in transgender individuals [<a href="#rid25">25</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Oral contraception [<a href="#rid26">26</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Hormone replacement therapy (oral [<a href="#rid27">27</a>] and topical [<a href="#rid28">28</a>])</p><p class="bulletIndent1"><span class="glyph">●</span>Menstrual cycle [<a href="#rid29">29,30</a>]. It is unknown if the association with SCAD is causal.</p><p></p><p class="headingAnchor" id="H734976276"><span class="h2">Genetic cause</span><span class="headingEndMark"> — </span>Recently identified associated genetic markers appear to increase the risk of SCAD; these require further investigation [<a href="#rid31">31-33</a>].</p><p class="headingAnchor" id="H1885129237"><span class="h2">Other disease associations</span><span class="headingEndMark"> — </span>Most patients presenting with SCAD do not have conventional risk factors for coronary heart disease [<a href="#rid7">7,10</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Migraines </strong>– In people with SCAD, migraines are common; studies have reported prevalence rates between 42 and 52 percent [<a href="#rid34">34,35</a>]. There may be a shared pathophysiology underlying SCAD and migraines; however, studies have not confirmed such pathways. One proposed shared mechanism is vascular dysfunction or link with FMD; in the latter, migraine is also frequently reported.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fibromuscular dysplasia </strong>– Among patients with SCAD, the coexistence of FMD is common. In a study of 168 patients with SCAD, FMD was found in about 80 percent [<a href="#rid10">10</a>]. In this study, which screened all patients with invasive or noninvasive angiography of the cerebral, iliac, or renal circulations, FMD was diagnosed in 72 percent in one or more territories. Other studies of patients with SCAD have found a similarly high prevalence of extracoronary vascular abnormalities, including FMD, dissection, tortuosity, and aneurysms [<a href="#rid16">16</a>]. In contrast, association with systemic inflammatory conditions appeared to account for a small proportion of cases [<a href="#rid7">7,10</a>] </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Connective tissue disorders </strong>– In a small proportion of cases (about 5 percent), SCAD can be associated with connective tissue diseases such as Marfan or vascular Ehlers-Danlos syndrome, where medial degeneration has been proposed to weaken the arterial wall and predispose to spontaneous dissections [<a href="#rid8">8,36,37</a>]. (See  <a class="medical medical_review" href="/z/d/html/14920.html" rel="external">"Clinical manifestations and diagnosis of Ehlers-Danlos syndromes"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Autoimmune disorders </strong>– Although case reports have raised the possibility that autoimmune disease is involved in the etiology of SCAD, a 2020 nested case control study of 114 people with SCAD and 342 control participants found no association between autoimmune disease and SCAD [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atherosclerosis </strong>–<strong> </strong>Atherosclerosis can cause coronary dissection, and it is a distinct variant, but it is excluded from the contemporary definition of nonatherosclerotic SCAD. (See <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="headingAnchor" id="H436342809"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H3368926005"><span class="h2">Common scenarios</span><span class="headingEndMark"> — </span>SCAD should be considered in any young patient who presents with an acute myocardial infarction or cardiac arrest, especially if they are female and have no risk factors or history of coronary heart disease. </p><p>The clinical presentations of acute myocardial infarction and cardiac arrest are discussed in detail separately: </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/184.html" rel="external">"Initial evaluation and management of suspected acute coronary syndrome (myocardial infarction, unstable angina) in the emergency department", section on 'Clinical presentation'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/184.html" rel="external">"Initial evaluation and management of suspected acute coronary syndrome (myocardial infarction, unstable angina) in the emergency department", section on 'Physical examination'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/963.html" rel="external">"Overview of sudden cardiac arrest and sudden cardiac death"</a>.)</p><p></p><p class="headingAnchor" id="H317003725"><span class="h3">Predisposing factors</span><span class="headingEndMark"> — </span>Other potential predisposing factors that may be present in patients upon history taking include the following [<a href="#rid7">7,8,10,39,40</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Fibromuscular dysplasia (FMD) (see  <a class="medical medical_review" href="/z/d/html/3874.html" rel="external">"Clinical manifestations and diagnosis of fibromuscular dysplasia"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Postpartum status, multiparity (≥4 births)</p><p class="bulletIndent1"><span class="glyph">●</span>Connective tissue disorders</p><p class="bulletIndent1"><span class="glyph">●</span>Systemic inflammatory conditions</p><p class="bulletIndent1"><span class="glyph">●</span>Hormonal therapy </p><p></p><p class="headingAnchor" id="H1284229178"><span class="h3">Triggers</span><span class="headingEndMark"> — </span>Several factors can trigger an episode of acute SCAD  (<a class="graphic graphic_table graphicRef141877" href="/z/d/graphic/141877.html" rel="external">table 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>Emotional stress – Emotional stress precede the event in approximately 50 percent of cases [<a href="#rid9">9,10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Exercise – Intense exertion precede the event in 28.9 percent of cases, including isometric stress lifting/pushing &gt;50 pounds in 9.8 percent of cases [<a href="#rid9">9,10</a>]. Males are more likely than females to have isometric exertion as a trigger of SCAD [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hormonal – Endogenous and exogenous sex hormones such as estrogen and progesterone may trigger SCAD. (See <a class="local">'Other hormonal causes'</a> above.) </p><p></p><p class="headingAnchor" id="H2535299233"><span class="h2">Signs and symptoms</span><span class="headingEndMark"> — </span>Patients with nonatherosclerotic SCAD usually present with signs and symptoms characteristic of acute coronary syndrome (ACS), including ischemic electrocardiographic (ECG) changes and elevated cardiac biomarkers, along with the following symptoms: </p><p class="bulletIndent1"><span class="glyph">●</span>Anginal chest pain (and/or arm, neck, or back discomfort)</p><p class="bulletIndent1"><span class="glyph">●</span>Diaphoresis</p><p class="bulletIndent1"><span class="glyph">●</span>Nausea and/or vomiting</p><p class="bulletIndent1"><span class="glyph">●</span>Dyspnea</p><p></p><p class="bulletIndent1">In a study of patients presenting with SCAD, chest pain was the most common symptom presentation in 96 percent of cases; less common symptoms include arm, neck, or back pain; nausea or vomiting; diaphoresis; and dyspnea [<a href="#rid1">1,7,41</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ECG changes </strong>– Among patients with acute SCAD, ischemic ST changes on ECG are very common [<a href="#rid42">42</a>]. In a registry of 1079 patients with SCAD who presented to the emergency department, the initial ECG showed ST elevation in 46 percent, T wave abnormality in 22 percent, and normal ECG in 16 percent of patients. A smaller proportion of patients had ST depression (6 percent) and ST abnormality 9 percent. (See  <a class="medical medical_review" href="/z/d/html/184.html" rel="external">"Initial evaluation and management of suspected acute coronary syndrome (myocardial infarction, unstable angina) in the emergency department", section on 'Clinical presentation'</a> and  <a class="medical medical_review" href="/z/d/html/1472.html" rel="external">"Approach to the patient with suspected angina pectoris"</a>.)</p><p></p><p class="headingAnchor" id="H436342816"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Once SCAD is suspected, coronary angiography should be performed as early as possible, especially if the ECG shows ST-segment elevation. (See  <a class="medical medical_review" href="/z/d/html/66.html" rel="external">"Overview of the acute management of ST-elevation myocardial infarction"</a>.)</p><p class="headingAnchor" id="H1875123710"><span class="h2">ECG</span><span class="headingEndMark"> — </span>In any patient with suspected SCAD, a 12-lead ECG is one of the first diagnostic steps. </p><p class="headingAnchor" id="H3363762635"><span class="h2">Echocardiography</span><span class="headingEndMark"> — </span>We routinely perform a transthoracic echocardiogram to assess left ventricular global and regional systolic function. In subtle angiographic cases of SCAD, focal wall motion abnormalities can help delineate potential sites of dissection. The echocardiogram is also useful for differentiating from Takotsubo syndrome, assessing left ventricular global and regional function at the point of care, and assessing prognosis. </p><p class="headingAnchor" id="H1532681695"><span class="h2">Coronary angiogram</span><span class="headingEndMark"> — </span>In the absence of prior trauma, the diagnosis of SCAD is made in most patients at the time of coronary angiography. A contemporary angiographic series has shown that stereotypical changes of intimal disruption with multiple radiolucent lumen were seen in &lt;30 percent of nonatherosclerotic SCAD cases [<a href="#rid8">8,10</a>]. The majority of SCAD cases had long and diffuse narrowing on angiography due to intramural hematoma, and this appearance was frequently unrecognized on angiography, leading to underdiagnosis of this condition.</p><p>The coronary angiographic appearance of SCAD has been classified into three types  (<a class="graphic graphic_diagnosticimage graphicRef98973 graphicRef98974 graphicRef98975" href="/z/d/graphic/98973.html" rel="external">image 1A-C</a>) [<a href="#rid43">43</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Type 1 </strong>– Pathognomonic contrast dye staining of arterial wall with multiple radiolucent lumen, with or without the presence of dye hang-up or slow contrast clearing [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Type 2 </strong>– Diffuse long and smooth stenosis that can vary in severity from mild stenosis to complete occlusion</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Type 3 </strong>– Mimics atherosclerosis with focal or tubular stenosis and requires optical coherence tomography (OCT) or intravascular ultrasound (IVUS) to differentiate the cause.</p><p></p><p>At the time of coronary angiography, the following findings were noted: </p><p class="bulletIndent1"><span class="glyph">●</span>The left anterior descending coronary artery was the most frequently affected vessel (in 40 to 70 percent of cases) [<a href="#rid7">7,9,10</a>]. The left main coronary artery was involved in 13 percent in one series that included only ST-elevation myocardial infarction SCAD patients [<a href="#rid4">4</a>], with other series showing much lower incidence of left main coronary artery involvement (approximately 2 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The most commonly observed angiographic type was 2 (60 to 67 percent) [<a href="#rid10">10</a>]. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most patients had only one coronary artery involved (approximately 87 percent), but multivessel involvement of noncontiguous coronary segments was not infrequent [<a href="#rid9">9,44</a>].</p><p></p><p>In patients for whom the diagnosis is considered but not secured with coronary angiography, the following adjunctive tests may be helpful: </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intracoronary imaging with OCT or IVUS </strong>– With these imaging modalities, the SCAD diagnosis can be made when intramural hematoma and/or a double lumen is seen. (See  <a class="medical medical_review" href="/z/d/html/16536.html" rel="external">"Intravascular ultrasound, optical coherence tomography, and angioscopy of coronary circulation"</a>.) </p><p></p><p>OCT has higher spatial resolution and can therefore identify intramural hematoma, endothelial tears, and the entry site of dissections  (<a class="graphic graphic_figure graphicRef141916" href="/z/d/graphic/141916.html" rel="external">figure 1</a>) [<a href="#rid45">45</a>]. The downsides of OCT in the diagnosis of SCAD include the possibility of propagating the false lumen due to the injection of contrast material required for imaging acquisition. IVUS has a higher tissue penetration depth compared with OCT and can characterize fibrous lesions and lipid collections. IVUS scan may be repeated during the same procedure.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Repeat coronary angiography </strong>– This may be pursued four to six weeks later if the diagnosis is uncertain; a finding of spontaneous angiographic healing of the dissected segment supports the diagnosis of SCAD.</p><p></p><p class="headingAnchor" id="H1308589187"><span class="h2">Alternative imaging tests</span><span class="headingEndMark"> — </span>These are not the tests of choice when SCAD is being strongly considered. However, in patients with troponin-negative chest pain, these may be a noninvasive imaging option to aid in diagnosis.</p><p class="headingAnchor" id="H2761781952"><span class="h3">Coronary computed tomographic imaging</span><span class="headingEndMark"> — </span>Some studies have suggested roles for cardiac computed tomography (CT) angiography [<a href="#rid46">46,47</a>] with suspected SCAD [<a href="#rid48">48</a>]. However, a substantial proportion of acute SCAD cases can be missed on CT angiography, and therefore this imaging modality should not be used as first-line imaging to diagnose SCAD. </p><p class="headingAnchor" id="H571704106"><span class="h3">Cardiac magnetic resonance imaging</span><span class="headingEndMark"> — </span>Cardiac magnetic resonance imaging can be useful to differentiate SCAD from other conditions in the differential diagnosis of myocardial infarction; this includes causes of nonischemic myocardial injury, such as Takotsubo syndrome or myocarditis [<a href="#rid49">49</a>]. (See  <a class="medical medical_review" href="/z/d/html/5314.html" rel="external">"Clinical utility of cardiovascular magnetic resonance imaging", section on 'Ischemic heart disease'</a>.)</p><p class="headingAnchor" id="H436342823"><span class="h1">MANAGEMENT</span></p><p class="headingAnchor" id="H1912113115"><span class="h2">Goals of therapy</span><span class="headingEndMark"> — </span>The goals of therapy are to preserve myocardial perfusion and cardiac function.</p><p class="headingAnchor" id="H2095821068"><span class="h2">Initial management</span><span class="headingEndMark"> — </span>In most SCAD patients, conservative therapy is the preferred strategy after the diagnosis is secured [<a href="#rid3">3,18,50</a>]; however, this depends on whether the patient is clinically stable or unstable. Also, the optimal management is uncertain, in part due to the limited clinical experience. </p><p>A wide range of approaches, including conservative management, emergency revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting, fibrinolytic therapy (with or without subsequent PCI), mechanical hemodynamic support, and cardiac transplantation have been reported [<a href="#rid10">10,11,51,52</a>].</p><p class="headingAnchor" id="H2467077199"><span class="h3">Stable patients</span><span class="headingEndMark"> — </span>Revascularization in patients with SCAD is technically challenging and associated with higher failure rates or complications [<a href="#rid7">7,10,50,53</a>]. A conservative approach is recommended unless there is ongoing ischemia, hemodynamic instability, or left main dissection. Angiographic "healing" of SCAD lesions has commonly been observed after conservative management [<a href="#rid3">3,10</a>]. The conservative approach to treating a myocardial infarction is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/66.html" rel="external">"Overview of the acute management of ST-elevation myocardial infarction"</a> and  <a class="medical medical_review" href="/z/d/html/66.html" rel="external">"Overview of the acute management of ST-elevation myocardial infarction", section on 'Patients who do not undergo reperfusion'</a>.)</p><p>Data regarding the most effective initial treatment for patients with SCAD are limited; there are no randomized studies of conservative versus invasive treatment of SCAD. Observational studies suggest that an initial conservative approach is associated with similar mortality and cardiovascular disease events compared with invasive treatment but is associated with a lower incidence of target vessel revascularization. A meta-analysis of 24 observational studies including 1720 patients with SCAD compared outcomes of a conservative versus invasive approach. In this study, 61 percent of patients had an initial conservative approach. After a mean follow-up of 28 months, a conservative approach had numerically but not statistically lower rates of all-cause mortality compared with an invasive approach (2.9 versus 4.8 percent; odds ratio 0.81; 95% CI 0.31-2.08). Rates of cardiovascular death, myocardial infarction, heart failure, and SCAD recurrence were also similar in the conservative versus invasive groups. Target vessel revascularization was lower with conservative versus invasive treatment (5.9 versus 13 percent; odds ratio 0.50; 95% CI 0.28-0.90). </p><p class="headingAnchor" id="H251940684"><span class="h3">Unstable patients</span><span class="headingEndMark"> — </span>In patients presenting with acute myocardial infarction who have symptoms of ongoing ischemia, hemodynamic compromise, or left main dissection, revascularization with PCI or coronary artery bypass grafting is generally pursued [<a href="#rid3">3,10</a>]. Fibrinolysis is not recommended for the treatment of SCAD.</p><p>Among 53 patients presenting with an ST-elevation myocardial infarction from SCAD, investigators report a 91 percent success rate with emergent PCI; however, the definition of success differed from other series [<a href="#rid4">4</a>]. The largest SCAD series to date of 750 patients reported a PCI success/partial success rate of 69.9 percent among 106 SCAD patients who underwent PCI [<a href="#rid9">9</a>]. </p><p>The in-hospital prognosis was generally good for those managed either conservatively or with coronary artery bypass grafting, while the short-term outcome appeared less favorable for those managed with PCI [<a href="#rid7">7,10,50</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>Acute PCI success was observed in less than 50 to 70 percent of cases [<a href="#rid9">9,10,50</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Long-term success with PCI without complication was observed in 30 percent only [<a href="#rid10">10</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Two-year major adverse event rate was 10 to 17 percent, with an observed recurrent dissection rate of 13 percent [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In 189 patients presenting with a first SCAD episode, procedural failure rate was 53 percent in those managed with PCI. In the subgroup of patients presenting with preserved vessel flow, PCI failure occurred in 50 percent of patients [<a href="#rid50">50</a>].</p><p></p><p>PCI should only be pursued when there is a strong clinical indication, and consideration should be given to utilizing adjunctive intracoronary imaging to optimize stent strut apposition. PCI with SCAD is often technically challenging in part due to fragility of the vessel wall. Advancing coronary guidewires within the true lumen can be challenging. Any instrumentation (wiring, angioplasty, or stenting) can propagate dissection and occlude side branches. In addition, dissections often affect small caliber distal vessels and are extensive, requiring long stents with high likelihood of subsequent in-stent restenosis. Furthermore, temporal resolution of intramural hematoma in previously stented segments may increase the risk of late stent malapposition and stent thrombosis. The use of bioabsorbable stents may have theoretical advantages [<a href="#rid23">23</a>]. The use of cutting balloon to fenestrate the false lumen to decrease burden of intramural hematoma compression of true lumen may also have utility [<a href="#rid54">54</a>].</p><p class="headingAnchor" id="H2335948611"><span class="h2">Long-term management</span></p><p class="headingAnchor" id="H3566897097"><span class="h3">Pharmacologic</span><span class="headingEndMark"> — </span>Patients are generally treated with long-term <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a>, beta blocker, and short-term <a class="drug drug_general" data-topicid="8921" href="/z/d/drug information/8921.html" rel="external">clopidogrel</a>, with the addition of a statin in patients with dyslipidemia [<a href="#rid10">10,55</a>]. There are no studies of the comparative effectiveness of these treatments in patients with SCAD. Ongoing prospective studies on SCAD should further elucidate the medical management of this challenging and relatively unexplored condition (NCT02188069 and NCT02008786).</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">Aspirin</a> – There are no randomized trials of aspirin therapy; the majority of patients with SCAD are given aspirin, preferably for the long term.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8921" href="/z/d/drug information/8921.html" rel="external">Clopidogrel</a> – Dual antiplatelet therapy is often given for 1 to 12 months following a SCAD event, although there is no supportive evidence with this therapy. It is reasonable to discontinue clopidogrel after healing of the dissection is confirmed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Beta blocker</strong> – Among 327 patients, the use of beta blocker was associated with lower risk of recurrent SCAD (hazard ratio 0.36, p = 0.004) in multivariable analysis in the large 327-patient cohort [<a href="#rid8">8</a>]. The use of a beta blocker is sometimes limited by fatigue and hypotension.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Statin</strong> – Statins are often given in patients with hyperlipidemia but not on a routine basis due to a theoretical concern that they can worsen the dissection [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antianginals</strong> – Patients with persistent chest pain post-SCAD may be treated with a long-acting nitrate or calcium channel blocker as needed.</p><p></p><p>The use of these medications among patients with acute coronary syndrome (ACS) or myocardial infarction is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/48.html" rel="external">"Overview of the nonacute management of unstable angina and non-ST-elevation myocardial infarction", section on 'Pharmacologic therapy'</a>.)</p><p class="headingAnchor" id="H1255007982"><span class="h3">Nonpharmacologic</span></p><p class="headingAnchor" id="H1624961897"><span class="h4">Avoidance of triggers</span><span class="headingEndMark"> — </span>If a suspected trigger for SCAD is discovered, we counsel patients to avoid the trigger (see <a class="local">'Triggers'</a> above). Treatments for specific triggers such as anxiety, depression, and trauma have not been well studied. </p><p class="headingAnchor" id="H522907465"><span class="h4">Activities after spontaneous coronary artery dissection</span><span class="headingEndMark"> — </span>We encourage patients to join a cardiac rehabilitation program after discharge. Although there are only a few differences in exercise recommendations for patients with SCAD compared with patients with myocardial infarction, a SCAD-specific rehabilitation program is recommended if available [<a href="#rid56">56</a>]. This program encompasses a multidisciplinary approach including exercise rehabilitation, psychosocial counselling, dietary and cardiovascular disease education, and peer group support. </p><p>Features of a cardiac rehabilitation program specific for patients with SCAD include the following: </p><p class="bulletIndent1"><span class="glyph">●</span>To reduce arterial shear stress, target exercise heart rate is recommended at 50 to 70 percent of heart rate reserve, and systolic blood pressure during exercise is limited to &lt;130 mmHg. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Exercise is adjusted to upper heart rate target to achieve rating of perceived exertion of "moderate" to "somewhat difficult." </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Women are instructed to avoid lifting weights &gt;20 to 30 pounds, and men should avoid lifting &gt;50 pounds. </p><p></p><p>Such a program was shown to be safe and beneficial in an uncontrolled cohort of 70 SCAD patients who experienced improvement in chest pain, exercise capacity, and psychosocial well-being [<a href="#rid56">56</a>]. Long term, we recommend avoidance of intense competitive exercise. </p><p class="headingAnchor" id="H2646847666"><span class="h4">Assessing for concomitant fibromuscular dysplasia</span><span class="headingEndMark"> — </span>Since a significant proportion of patients with SCAD have associated extracoronary fibromuscular dysplasia (FMD) (see <a class="local">'Other disease associations'</a> above), we obtain full-body cross-sectional imaging (preferably with computed tomographic [CT] angiography) to diagnose concomitant FMD [<a href="#rid3">3,57,58</a>]. We only perform imaging for FMD with magnetic resonance angiography if the patient refused CT angiography (due to lower resolution of magnetic resonance angiography).</p><p>The screening and management of FMD are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/3874.html" rel="external">"Clinical manifestations and diagnosis of fibromuscular dysplasia"</a> and  <a class="medical medical_review" href="/z/d/html/3826.html" rel="external">"Treatment of fibromuscular dysplasia of the renal arteries"</a>.)</p><p>Extracoronary FMD can predict long-term major adverse coronary events [<a href="#rid59">59</a>]. This was shown in a prospective cohort study in which 750 patients with SCAD were followed for a median of three years for major adverse coronary events (MACE; this was defined as mortality, recurrent myocardial infarction, extension of previous SCAD or de novo recurrent SCAD, and iatrogenic dissection). MACE occurred in 14 percent, and those with FMD had a higher hazard of MACE (hazard ratio 1.51, p &lt;0.04). </p><p class="headingAnchor" id="H223649175"><span class="h4">Recurrent chest pain</span><span class="headingEndMark"> — </span>In patients with SCAD, recurrent chest pain is common. Forty percent of individuals experienced recurrence of their chest pain after initial hospitalization for SCAD, and 16.5 percent were diagnosed with recurrent SCAD [<a href="#rid42">42</a>]. When a patient diagnosed with SCAD presents with recurrent chest pain, we generally pursue the same diagnostic work-up as we would in a patient initially presenting with SCAD. (See <a class="local">'Initial management'</a> above.)</p><p class="headingAnchor" id="H925849787"><span class="h3">Repeat coronary angiography</span><span class="headingEndMark"> — </span>Repeat angiography is performed if clinically indicated (for patients presenting with another ACS) and in some cases, if the initial angiogram was not definitive. </p><p class="headingAnchor" id="H489287840"><span class="h3">Other cardiovascular conditions</span><span class="headingEndMark"> — </span>Meticulous control of hypertension is recommended. Chronic treatment of ischemic cardiomyopathy follows guidelines for non-SCAD indications. </p><p class="headingAnchor" id="H436342830"><span class="h1">SEQUELAE</span><span class="headingEndMark"> — </span>In a prospective multicenter study of 750 patients with SCAD (Canadian SCAD Cohort Study), the in-hospital major adverse event rate was 8.8 percent; adverse events included mortality, recurrent myocardial infarction, cardiogenic shock, and unplanned revascularization [<a href="#rid9">9</a>]. </p><p>Sequelae can be divided into those occurring proximate to the initial SCAD presentation and those occurring months to years afterwards. </p><p class="headingAnchor" id="H1612324903"><span class="h2">Acute</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>In-hospital myocardial infarction </strong>– In a cohort of 327 patients who were followed prospectively (median follow-up 3.1 years) and in whom an initial conservative approach was applied in 83 percent, the recurrent in-hospital myocardial infarction rate was 4.6 percent, with unplanned revascularization occurring in 4.3 percent [<a href="#rid7">7,10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ventricular arrhythmias </strong>– Life-threatening ventricular arrhythmias have been reported in 4 to 14 percent of patients with SCAD [<a href="#rid7">7,9,10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiogenic shock </strong>– This was reported in 2 to 19 percent of patients with SCAD; not surprisingly, patients with ST-elevation myocardial infarction had a higher prevalence of shock [<a href="#rid4">4,10</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dissection in noncoronary vascular beds </strong>– SCAD patients may simultaneously present with dissections in other vascular beds, such as the carotid or vertebral arteries [<a href="#rid44">44</a>]. This highlights that a subset of patients may have a systemic predisposing arteriopathy compounded by an intense systemic precipitating milieu (be it hormonal, inflammatory, emotional, or physical), which may complicate their presenting symptoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>In-hospital</strong> <strong>mortality </strong>–<strong> </strong>In a population-based national administrative database from 2004 to 2015, 66,360 patients were reported to have SCAD, and the in-hospital mortality was 4.2 percent [<a href="#rid5">5</a>]. In a prospective multicenter study of 750 patients with SCAD (Canadian SCAD Cohort Study), in-hospital mortality was relatively low at 0.1 percent [<a href="#rid9">9</a>].</p><p></p><p class="headingAnchor" id="H497625162"><span class="h2">Long-term</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recurrent myocardial infarction </strong>– In a prospective study of 750 patients with SCAD from 22 centers in North America (Canadian SCAD Cohort Study), over a 3.1-year follow-up, 16.8 percent had recurrent myocardial infarction. ST-elevation myocardial infarction was present in 25 to 50 percent of patients, with the remainder presenting with non-ST-elevation myocardial infarction [<a href="#rid10">10</a>]. Very rarely (&lt;1 percent of cases), there was no troponin elevation [<a href="#rid9">9</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recurrent SCAD </strong>–<strong> </strong>In a multicenter prospective study, 750 patients with SCAD (Canadian SCAD Cohort Study) were followed for 3.1 years; 10.4 percent had recurrent SCAD [<a href="#rid9">9</a>]. In a separate series of 87 patients after a median of 47 months, the recurrence of SCAD was 17 percent [<a href="#rid7">7</a>]. In these patients, coronary tortuosity may be associated with a higher risk of recurrent SCAD [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Long-term</strong> <strong>mortality </strong>– In the Canadian SCAD cohort study described above, the mortality rate at the three-year median follow-up was 0.8 percent [<a href="#rid10">10</a>]. </p><p></p><p class="bulletIndent1">Further prospective and ongoing SCAD studies (Canadian SCAD Cohort Study [NCT02188069] and the "Virtual" Mayo Clinic SCAD Registry [NCT01429727]) will help elucidate the long-term cardiovascular outcome of this condition.</p><p></p><p class="headingAnchor" id="H3708586485"><span class="h1">PREGNANCY, PRECONCEPTION COUNSELING, AND CONTRACEPTION</span><span class="headingEndMark"> — </span>In patients who had prior SCAD who are considering pregnancy or who are already pregnant, the timing, features, and prognosis of pregnancy-associated SCAD are important to discuss. When discussing pregnancy with patients with a history of SCAD, we emphasize potential risks, and if they choose to become pregnant, patients will require high-risk pregnancy multidisciplinary care.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pregnancy-associated SCAD </strong>–<strong> </strong>This most often presents early postpartum and is associated with a more severe presentation compared with SCAD not associated with pregnancy. </p><p></p><p class="bulletIndent1">In a single-center registry including 54 females with pregnancy-associated SCAD, four people presented during pregnancy (7.4 percent), 48 within 12 weeks following delivery (89 percent), one following a first trimester miscarriage (2 percent), and one following a stillbirth at 36 weeks (2 percent) [<a href="#rid60">60</a>]. These findings were similar to a study from Kaiser Permanente Northern California in which 18 of 22 females with pregnancy-associated SCAD presented postpartum (81 percent) [<a href="#rid61">61</a>]. In both studies, the majority of patients presenting with SCAD postpartum did so within the first month post-delivery (70 to 83 percent) [<a href="#rid60">60,61</a>]. </p><p></p><p class="bulletIndent1">Although no patients died from pregnancy-associated SCAD in either registry, both studies showed that people who had SCAD during pregnancy had more severe presentations compared with those who had SCAD that was not related to pregnancy [<a href="#rid60">60,61</a>]. Patients with pregnancy-associated SCAD had more proximal and multivessel coronary artery dissections, more heart failure, and lower average left ventricular ejection fraction on presentation compared with patients with SCAD not associated with a pregnancy. A separate study analyzed 13 patients who had died from pregnancy-associated SCAD from the MBRRACE-UK registry [<a href="#rid62">62</a>]. Among these deaths, three occurred during pregnancy, and 10 occurred postpartum (median 16 days postpartum [range 10 to 94]). Twelve patients had an out-of-hospital cardiac arrest; three underwent angiography, including one female who was alive at presentation to the hospital and two females who had angiography during active resuscitation. None underwent revascularization. Females who did not have angiography had autopsy-confirmed SCAD. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recurrence of SCAD with pregnancy </strong>– In people with SCAD (whether pregnancy related or not), there is a risk of recurrence during pregnancy or the postpartum period. Data from multiple SCAD registries were combined to evaluate 82 patients with pregnancy-associated SCAD [<a href="#rid62">62</a>], including the 13 from the previously mentioned United Kingdom registry who died. In the subset of 28 patients who had 37 pregnancies after their initial SCAD diagnosis, the following observations were reported: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Conception after the most recent SCAD event occurred after a median of 30 months. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Three women opted for medical termination (because of medical advice received about the risk of pregnancy), and seven spontaneous miscarriages occurred in three patients. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Three pregnancy-associated major adverse cardiovascular and cerebrovascular events occurred. One was recurrent acute myocardial infarction at 19 weeks of gestation (this was thought to be recurrent SCAD and was managed without invasive angiography); the other two were angiographically confirmed recurrent SCAD events occurring within 12 months of delivery. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>No maternal or neonatal deaths were reported among those with prior SCAD who became pregnant.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Contraception </strong>– We generally avoid estrogen-containing contraceptives, although the risk of adverse events in patients with SCAD has not been well studied.</p><p></p><p class="headingAnchor" id="H3108450198"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/114034.html" rel="external">"Society guideline links: Non-ST-elevation acute coronary syndromes (non-ST-elevation myocardial infarction)"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/113180.html" rel="external">"Society guideline links: ST-elevation myocardial infarction (STEMI)"</a>.)</p><p class="headingAnchor" id="H436342837"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition and epidemiology </strong>– Spontaneous coronary artery dissection (SCAD) is defined as a nontraumatic and noniatrogenic separation of the coronary arterial wall. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1">The incidence of SCAD is 0.5 to 0.7 among patients with acute coronary syndrome (ACS) and referred for angiography, respectively. It is likely more common in younger females presenting with ACS. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disease associations </strong>– Twenty percent of SCAD cases are idiopathic; other patients are pregnant or postpartum, have fibromuscular dysplasia (FMD), connective tissue disorders, and other associated conditions.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations </strong>– While uncommon, SCAD should be considered in any young patient, especially females, without a history of coronary heart disease or risk factors and who present with an acute myocardial infarction or cardiac arrest. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis </strong>– The diagnosis is usually made at the time of urgent coronary angiography. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Initial management </strong>– We suggest conservative therapy as the preferred strategy for most patients, particularly those who are clinically stable (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Stable patients'</a> above.)</p><p></p><p class="bulletIndent2">In patients presenting with acute myocardial infarction who have symptoms of ongoing ischemia, hemodynamic compromise, or left main dissection, we suggest revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Unstable patients'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Long-term management </strong>– We suggest that patients with SCAD be treated with antiplatelet and beta blocker therapy. Specific medications and duration of medication have not well studied; it is reasonable to discuss the duration of therapy with the patient in shared decision-making (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Long-term management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sequelae </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Acute sequelae</strong> – Acute sequelae include in-hospital myocardial infarction, ventricular arrythmia, cardiogenic shock, and in-hospital mortality. (See <a class="local">'Acute'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Long-term sequelae</strong> – Long-term sequelae include recurrent myocardial infarction (17 percent) and recurrent SCAD (in 10 to 17 percent). Long-term mortality rates are relatively low in patients with SCAD (0.8 percent after three years). (See <a class="local">'Long-term'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pregnancy, preconception counseling, and contraception</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In patients with existing SCAD who are considering getting pregnant or who are pregnant, the timing, features, and prognosis of pregnancy-associated SCAD are important to discuss. (See <a class="local">'Pregnancy, preconception counseling, and contraception'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pregnancy-associated SCAD is most likely to occur in the first month postpartum. Although pregnancy-related SCAD has a more severe presentation than non-pregnancy-related SCAD, the occurrence of death is rare. Most pregnancy-associated SCAD deaths occur postpartum and as a result of an arrhythmia. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Among females with a diagnosis of SCAD, there is a risk of recurrence during pregnancy or the postpartum period. If pregnancy is desired or takes place, referral to a team of providers (including a cardiologist) who manage high-risk pregnancies is recommended.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We generally avoid estrogen-containing contraceptives, although the risk of adverse events in patients with SCAD has not been well studied.</p><p></p><p class="headingAnchor" id="H3004532155"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff thank Pamela S. Douglas, MD, for her past contributions as an author to prior versions of this topic review. </p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Mortensen KH, Thuesen L, Kristensen IB, Christiansen EH. Spontaneous coronary artery dissection: a Western Denmark Heart Registry study. Catheter Cardiovasc Interv 2009; 74:710.</a></li><li><a class="nounderline abstract_t">Nishiguchi T, Tanaka A, Ozaki Y, et al. Prevalence of spontaneous coronary artery dissection in patients with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care 2016; 5:263.</a></li><li><a class="nounderline abstract_t">Hayes SN, Kim ESH, Saw J, et al. Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association. Circulation 2018; 137:e523.</a></li><li><a class="nounderline abstract_t">Lobo AS, Cantu SM, Sharkey SW, et al. Revascularization in Patients With Spontaneous Coronary Artery Dissection and ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol 2019; 74:1290.</a></li><li><a class="nounderline abstract_t">Krittanawong C, Kumar A, Virk HUH, et al. Trends in Incidence, Characteristics, and In-Hospital Outcomes of Patients Presenting With Spontaneous Coronary Artery Dissection (From a National Population-Based Cohort Study Between 2004 and 2015). Am J Cardiol 2018; 122:1617.</a></li><li><a class="nounderline abstract_t">Mahmoud AN, Taduru SS, Mentias A, et al. Trends of Incidence, Clinical Presentation, and In-Hospital Mortality Among Women With Acute Myocardial Infarction With or Without Spontaneous Coronary Artery Dissection: A Population-Based Analysis. JACC Cardiovasc Interv 2018; 11:80.</a></li><li><a class="nounderline abstract_t">Tweet MS, Hayes SN, Pitta SR, et al. Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation 2012; 126:579.</a></li><li><a class="nounderline abstract_t">Saw J, Humphries K, Aymong E, et al. Spontaneous Coronary Artery Dissection: Clinical Outcomes and Risk of Recurrence. J Am Coll Cardiol 2017; 70:1148.</a></li><li><a class="nounderline abstract_t">Saw J, Starovoytov A, Humphries K, et al. Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes. Eur Heart J 2019; 40:1188.</a></li><li><a class="nounderline abstract_t">Saw J, Aymong E, Sedlak T, et al. Spontaneous coronary artery dissection: association with predisposing arteriopathies and precipitating stressors and cardiovascular outcomes. Circ Cardiovasc Interv 2014; 7:645.</a></li><li><a class="nounderline abstract_t">Alfonso F, Paulo M, Lennie V, et al. Spontaneous coronary artery dissection: long-term follow-up of a large series of patients prospectively managed with a "conservative" therapeutic strategy. JACC Cardiovasc Interv 2012; 5:1062.</a></li><li><a class="nounderline abstract_t">Fahmy P, Prakash R, Starovoytov A, et al. Pre-Disposing and Precipitating Factors in Men With Spontaneous Coronary Artery Dissection. JACC Cardiovasc Interv 2016; 9:866.</a></li><li><a class="nounderline abstract_t">Alfonso F. Spontaneous coronary artery dissection: new insights from the tip of the iceberg? Circulation 2012; 126:667.</a></li><li><a class="nounderline abstract_t">Alfonso F, Bastante T. Spontaneous coronary artery dissection: novel diagnostic insights from large series of patients. Circ Cardiovasc Interv 2014; 7:638.</a></li><li><a class="nounderline abstract_t">Basso C, Morgagni GL, Thiene G. Spontaneous coronary artery dissection: a neglected cause of acute myocardial ischaemia and sudden death. Heart 1996; 75:451.</a></li><li><a class="nounderline abstract_t">Eleid MF, Guddeti RR, Tweet MS, et al. Coronary artery tortuosity in spontaneous coronary artery dissection: angiographic characteristics and clinical implications. Circ Cardiovasc Interv 2014; 7:656.</a></li><li><a class="nounderline abstract_t">Saw J, Bezerra H, Gornik HL, et al. Angiographic and Intracoronary Manifestations of Coronary Fibromuscular Dysplasia. Circulation 2016; 133:1548.</a></li><li><a class="nounderline abstract_t">Saw J, Mancini GB, Humphries KH. Contemporary Review on Spontaneous Coronary Artery Dissection. J Am Coll Cardiol 2016; 68:297.</a></li><li><a class="nounderline abstract_t">Saw J, Mancini GB, Humphries K, et al. Angiographic appearance of spontaneous coronary artery dissection with intramural hematoma proven on intracoronary imaging. Catheter Cardiovasc Interv 2016; 87:E54.</a></li><li><a class="nounderline abstract_t">Alfonso F, Paulo M, Gonzalo N, et al. Diagnosis of spontaneous coronary artery dissection by optical coherence tomography. J Am Coll Cardiol 2012; 59:1073.</a></li><li><a class="nounderline abstract_t">Isner JM, Donaldson RF, Fortin AH, et al. Attenuation of the media of coronary arteries in advanced atherosclerosis. Am J Cardiol 1986; 58:937.</a></li><li><a class="nounderline abstract_t">Saw J, Ricci D, Starovoytov A, et al. Spontaneous coronary artery dissection: prevalence of predisposing conditions including fibromuscular dysplasia in a tertiary center cohort. JACC Cardiovasc Interv 2013; 6:44.</a></li><li><a class="nounderline abstract_t">Vijayaraghavan R, Verma S, Gupta N, Saw J. Pregnancy-related spontaneous coronary artery dissection. Circulation 2014; 130:1915.</a></li><li><a class="nounderline abstract_t">Iyasere C, Potdar N. Spontaneous Coronary Artery Dissection Associated With Infertility Treatment. Cureus 2022; 14:e29587.</a></li><li><a class="nounderline abstract_t">Hirsch K, Yogeswaran V, Dean LS. Spontaneous coronary artery dissection and exogenous estrogen in a transgender female. Catheter Cardiovasc Interv 2022; 100:96.</a></li><li><a class="nounderline abstract_t">Evangelou D, Letsas KP, Korantzopoulos P, et al. Spontaneous coronary artery dissection associated with oral contraceptive use: a case report and review of the literature. Int J Cardiol 2006; 112:380.</a></li><li><a class="nounderline abstract_t">Mori R, Macaya F, Giacobbe F, et al. Association between hormone therapy and short-term cardiovascular events in women with spontaneous coronary artery dissection. Rev Esp Cardiol (Engl Ed) 2023; 76:165.</a></li><li><a class="nounderline abstract_t">Pan AL, Fergusson D, Hong R, Badawi RA. Spontaneous Coronary Artery Dissection following Topical Hormone Replacement Therapy. Case Rep Cardiol 2012; 2012:524508.</a></li><li><a class="nounderline abstract_t">Skelding KA, Hubbard CR. Spontaneous coronary artery dissection related to menstruation. J Invasive Cardiol 2007; 19:E174.</a></li><li><a class="nounderline abstract_t">Marcoff L, Rahman E. Menstruation-associated spontaneous coronary artery dissection. J Invasive Cardiol 2010; 22:E183.</a></li><li><a class="nounderline abstract_t">Sun Y, Chen Y, Li Y, et al. Association of TSR1 Variants and Spontaneous Coronary Artery Dissection. J Am Coll Cardiol 2019; 74:167.</a></li><li><a class="nounderline abstract_t">Goel K, Tweet M, Olson TM, et al. Familial spontaneous coronary artery dissection: evidence for genetic susceptibility. JAMA Intern Med 2015; 175:821.</a></li><li><a class="nounderline abstract_t">Adlam D, Olson TM, Combaret N, et al. Association of the PHACTR1/EDN1 Genetic Locus With Spontaneous Coronary Artery Dissection. J Am Coll Cardiol 2019; 73:58.</a></li><li><a class="nounderline abstract_t">Kok SN, Hayes SN, Cutrer FM, et al. Prevalence and Clinical Factors of Migraine in Patients With Spontaneous Coronary Artery Dissection. J Am Heart Assoc 2018; 7:e010140.</a></li><li><a class="nounderline abstract_t">Smaardijk VR, Mommersteeg PMC, Kop WJ, et al. Psychological and clinical characteristics of patients with spontaneous coronary artery dissection: A case-control study. Int J Cardiol 2021; 323:1.</a></li><li><a class="nounderline abstract_t">Judge DP, Dietz HC. Marfan's syndrome. Lancet 2005; 366:1965.</a></li><li><a class="nounderline abstract_t">Adès LC, Waltham RD, Chiodo AA, Bateman JF. Myocardial infarction resulting from coronary artery dissection in an adolescent with Ehlers-Danlos syndrome type IV due to a type III collagen mutation. Br Heart J 1995; 74:112.</a></li><li><a class="nounderline abstract_t">Kronzer VL, Tarabochia AD, Lobo Romero AS, et al. Lack of Association of Spontaneous Coronary Artery Dissection With Autoimmune Disease. J Am Coll Cardiol 2020; 76:2226.</a></li><li><a class="nounderline abstract_t">Saw J, Poulter R, Fung A, et al. Spontaneous coronary artery dissection in patients with fibromuscular dysplasia: a case series. Circ Cardiovasc Interv 2012; 5:134.</a></li><li><a class="nounderline abstract_t">Michelis KC, Olin JW, Kadian-Dodov D, et al. Coronary artery manifestations of fibromuscular dysplasia. J Am Coll Cardiol 2014; 64:1033.</a></li><li><a class="nounderline abstract_t">Luong C, Starovoytov A, Heydari M, et al. Clinical presentation of patients with spontaneous coronary artery dissection. Catheter Cardiovasc Interv 2017; 89:1149.</a></li><li><a class="nounderline abstract_t">Johnson AK, Tweet MS, Rouleau SG, et al. The presentation of spontaneous coronary artery dissection in the emergency department: Signs and symptoms in an unsuspecting population. Acad Emerg Med 2022; 29:423.</a></li><li><a class="nounderline abstract_t">Saw J. Coronary angiogram classification of spontaneous coronary artery dissection. Catheter Cardiovasc Interv 2014; 84:1115.</a></li><li><a class="nounderline abstract_t">Lempereur M, Gin K, Saw J. Multivessel spontaneous coronary artery dissection mimicking atherosclerosis. JACC Cardiovasc Interv 2014; 7:e87.</a></li><li><a class="nounderline abstract_t">Barbieri L, D'Errico A, Avallone C, et al. Optical Coherence Tomography and Coronary Dissection: Precious Tool or Useless Surplus? Front Cardiovasc Med 2022; 9:822998.</a></li><li><a class="nounderline abstract_t">Pozo-Osinalde E, García-Guimaraes M, Bastante T, et al. Characteristic findings of acute spontaneous coronary artery dissection by cardiac computed tomography. Coron Artery Dis 2020; 31:293.</a></li><li><a class="nounderline abstract_t">Tweet MS, Akhtar NJ, Hayes SN, et al. Spontaneous coronary artery dissection: Acute findings on coronary computed tomography angiography. Eur Heart J Acute Cardiovasc Care 2019; 8:467.</a></li><li><a class="nounderline abstract_t">Tan NY, Hayes SN, Young PM, et al. Usefulness of Cardiac Magnetic Resonance Imaging in Patients With Acute Spontaneous Coronary Artery Dissection. Am J Cardiol 2018; 122:1624.</a></li><li><a class="nounderline abstract_t">Saw J. Is there a role for cardiac magnetic resonance imaging in patients with SCAD? Eur Heart J 2020; 41:2206.</a></li><li><a class="nounderline abstract_t">Tweet MS, Eleid MF, Best PJ, et al. Spontaneous coronary artery dissection: revascularization versus conservative therapy. Circ Cardiovasc Interv 2014; 7:777.</a></li><li><a class="nounderline abstract_t">Saw J, Aymong E, Mancini GB, et al. Nonatherosclerotic coronary artery disease in young women. Can J Cardiol 2014; 30:814.</a></li><li><a class="nounderline abstract_t">Higgins GL 3rd, Borofsky JS, Irish CB, et al. Spontaneous peripartum coronary artery dissection presentation and outcome. J Am Board Fam Med 2013; 26:82.</a></li><li><a class="nounderline abstract_t">Vrints CJ. Spontaneous coronary artery dissection. Heart 2010; 96:801.</a></li><li><a class="nounderline abstract_t">Main A, Lombardi WL, Saw J. Cutting balloon angioplasty for treatment of spontaneous coronary artery dissection: case report, literature review, and recommended technical approaches. Cardiovasc Diagn Ther 2019; 9:50.</a></li><li><a class="nounderline abstract_t">Saw J. Spontaneous coronary artery dissection. Can J Cardiol 2013; 29:1027.</a></li><li><a class="nounderline abstract_t">Chou AY, Prakash R, Rajala J, et al. The First Dedicated Cardiac Rehabilitation Program for Patients With Spontaneous Coronary Artery Dissection: Description and Initial Results. Can J Cardiol 2016; 32:554.</a></li><li><a class="nounderline abstract_t">Saw J, Sedlak T, Ganesh SK, et al. Cardiology patient page. Spontaneous coronary artery dissection (SCAD). Circulation 2015; 131:e3.</a></li><li><a class="nounderline abstract_t">Tweet MS, Gulati R, Hayes SN. What Clinicians Should Know Αbout Spontaneous Coronary Artery Dissection. Mayo Clin Proc 2015; 90:1125.</a></li><li><a class="nounderline abstract_t">Saw J, Starovoytov A, Aymong E, et al. Canadian Spontaneous Coronary Artery Dissection Cohort Study: 3-Year Outcomes. J Am Coll Cardiol 2022; 80:1585.</a></li><li><a class="nounderline abstract_t">Tweet MS, Hayes SN, Codsi E, et al. Spontaneous Coronary Artery Dissection Associated With Pregnancy. J Am Coll Cardiol 2017; 70:426.</a></li><li><a class="nounderline abstract_t">Chen S, Merchant M, Mahrer KN, et al. Pregnancy-Associated Spontaneous Coronary Artery Dissection: Clinical Characteristics, Outcomes, and Risk During Subsequent Pregnancy. J Invasive Cardiol 2021; 33:E457.</a></li><li><a class="nounderline abstract_t">Chan N, Premawardhana D, Al-Hussaini A, et al. Pregnancy and Spontaneous Coronary Artery Dissection: Lessons From Survivors and Nonsurvivors. Circulation 2022; 146:69.</a></li></ol></div><div id="topicVersionRevision">Topic 97665 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19496145" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Spontaneous coronary artery dissection: a Western Denmark Heart Registry study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24585938" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Prevalence of spontaneous coronary artery dissection in patients with acute coronary syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29472380" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31488265" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Revascularization in Patients With Spontaneous Coronary Artery Dissection and ST-Segment Elevation Myocardial Infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30293656" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Trends in Incidence, Characteristics, and In-Hospital Outcomes of Patients Presenting With Spontaneous Coronary Artery Dissection (From a National Population-Based Cohort Study Between 2004 and 2015).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29248409" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Trends of Incidence, Clinical Presentation, and In-Hospital Mortality Among Women With Acute Myocardial Infarction With or Without Spontaneous Coronary Artery Dissection: A Population-Based Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22800851" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Clinical features, management, and prognosis of spontaneous coronary artery dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28838364" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Spontaneous Coronary Artery Dissection: Clinical Outcomes and Risk of Recurrence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30698711" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25294399" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Spontaneous coronary artery dissection: association with predisposing arteriopathies and precipitating stressors and cardiovascular outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23078737" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Spontaneous coronary artery dissection: long-term follow-up of a large series of patients prospectively managed with a "conservative" therapeutic strategy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27101917" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Pre-Disposing and Precipitating Factors in Men With Spontaneous Coronary Artery Dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22800852" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Spontaneous coronary artery dissection: new insights from the tip of the iceberg?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25336602" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Spontaneous coronary artery dissection: novel diagnostic insights from large series of patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8665336" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Spontaneous coronary artery dissection: a neglected cause of acute myocardial ischaemia and sudden death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25138034" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Coronary artery tortuosity in spontaneous coronary artery dissection: angiographic characteristics and clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26957531" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Angiographic and Intracoronary Manifestations of Coronary Fibromuscular Dysplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27417009" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Contemporary Review on Spontaneous Coronary Artery Dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26198289" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Angiographic appearance of spontaneous coronary artery dissection with intramural hematoma proven on intracoronary imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22421300" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Diagnosis of spontaneous coronary artery dissection by optical coherence tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3776849" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Attenuation of the media of coronary arteries in advanced atherosclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23266235" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Spontaneous coronary artery dissection: prevalence of predisposing conditions including fibromuscular dysplasia in a tertiary center cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25403597" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Pregnancy-related spontaneous coronary artery dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36312665" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Spontaneous Coronary Artery Dissection Associated With Infertility Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35445791" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Spontaneous coronary artery dissection and exogenous estrogen in a transgender female.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16256224" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Spontaneous coronary artery dissection associated with oral contraceptive use: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35850485" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Association between hormone therapy and short-term cardiovascular events in women with spontaneous coronary artery dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24826258" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Spontaneous Coronary Artery Dissection following Topical Hormone Replacement Therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17541143" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Spontaneous coronary artery dissection related to menstruation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20944194" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Menstruation-associated spontaneous coronary artery dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31296287" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Association of TSR1 Variants and Spontaneous Coronary Artery Dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25798899" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Familial spontaneous coronary artery dissection: evidence for genetic susceptibility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30621952" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Association of the PHACTR1/EDN1 Genetic Locus With Spontaneous Coronary Artery Dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30561271" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Prevalence and Clinical Factors of Migraine in Patients With Spontaneous Coronary Artery Dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32798624" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Psychological and clinical characteristics of patients with spontaneous coronary artery dissection: A case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16325700" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Marfan's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7546986" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Myocardial infarction resulting from coronary artery dissection in an adolescent with Ehlers-Danlos syndrome type IV due to a type III collagen mutation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33153582" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Lack of Association of Spontaneous Coronary Artery Dissection With Autoimmune Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22338003" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Spontaneous coronary artery dissection in patients with fibromuscular dysplasia: a case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25190240" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Coronary artery manifestations of fibromuscular dysplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28244197" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Clinical presentation of patients with spontaneous coronary artery dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34897898" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The presentation of spontaneous coronary artery dissection in the emergency department: Signs and symptoms in an unsuspecting population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24227590" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Coronary angiogram classification of spontaneous coronary artery dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25060032" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Multivessel spontaneous coronary artery dissection mimicking atherosclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35433885" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Optical Coherence Tomography and Coronary Dissection: Precious Tool or Useless Surplus?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31658141" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Characteristic findings of acute spontaneous coronary artery dissection by cardiac computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29376398" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Spontaneous coronary artery dissection: Acute findings on coronary computed tomography angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30220414" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Usefulness of Cardiac Magnetic Resonance Imaging in Patients With Acute Spontaneous Coronary Artery Dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32031604" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Is there a role for cardiac magnetic resonance imaging in patients with SCAD?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25406203" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Spontaneous coronary artery dissection: revascularization versus conservative therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24726091" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Nonatherosclerotic coronary artery disease in young women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23288285" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Spontaneous peripartum coronary artery dissection presentation and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20448134" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Spontaneous coronary artery dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30881877" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Cutting balloon angioplasty for treatment of spontaneous coronary artery dissection: case report, literature review, and recommended technical approaches.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23498840" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Spontaneous coronary artery dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26923234" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The First Dedicated Cardiac Rehabilitation Program for Patients With Spontaneous Coronary Artery Dissection: Description and Initial Results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25561479" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Cardiology patient page. Spontaneous coronary artery dissection (SCAD).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26250728" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : What Clinicians Should KnowΑbout Spontaneous Coronary Artery Dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36265953" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Canadian Spontaneous Coronary Artery Dissection Cohort Study: 3-Year Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28728686" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Spontaneous Coronary Artery Dissection Associated With Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34001675" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Pregnancy-Associated Spontaneous Coronary Artery Dissection: Clinical Characteristics, Outcomes, and Risk During Subsequent Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35656808" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Pregnancy and Spontaneous Coronary Artery Dissection: Lessons From Survivors and Nonsurvivors.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
